Bio Integrates 2021 Track 3


What does the future hold for life science investment, intellect and infrastructure?

Welcome and opening remarks

MARTINO PICARDO | Chairman | Discovery Park

We are sorry that we had a few technical issues at the start of the day, so we only have the audio file of Martino’s opening remarks

A fireside chat with Andreas Wallnoefer

An interview with: ANDREAS WALLNOEFER | Partner & Investor | Jeito Capital
Interviewed by: MARTINO PICARDO | Chairman | Discovery Park

A fireside chat with Ruth McKernan CBE

An Interview with: Dr RUTH McKERNAN CBE | Neuroscientist, businesswoman and innovation leader
Interviewed by: TREVOR JONES CBE | Chairman and Board Member | e-Therapeutics, Respiratory Innovation Wales and Ascension Healthcare

Go big or go home

The Government’s Industrial Strategy and commitment to life science funding relies on companies scaling their science in the UK. How do you scale up in a fragmented ecosystem?


DR SALLY ANN FORSYTH OBE | Chief Executive Officer | Stevenage Bioscience Catalyst


GLENN CROCKER MBE | Director of Ventures and Investment | We are Pioneer
JULIANNA HAGGERTY | Head of Centre of Excellence – Lipid Nanoparticles | CPI
ANDY RICHARDS CBE | Chairman | Congenica, Abcodia, Closed Loop Medicine, Arecor, Ieso Digital Health
OLIVIA DREW | Director | UBS
IRENE GRAHAM OBE | CEO | ScaleUp Institute
NICK JOHNSON | Chief Strategy Officer | Cell and Gene Therapy Catapult

Value in, value out

With a greater focus on accelerating development timelines, investors are expecting quicker returns. How can we accelerate products to deliver maximum value for patients and investors?


KATH MACKAY | Director of Life Sciences | Bruntwood SciTech – Alderley Park


ANDY HILL | Chief Executive Officer | Nu-Vision Biotherapies
KOUJIRO TAMBARA | Principal | Downing
LOUWAI MUHAMMED | CEO and Co-Founder | CoSyne Therapeutics
CLARE TRIPPETT | Chief Technologist – Biologics | CPI
MARTIN DOORBAR | Chief Development Officer; Non Clinical |  Ellipses
JAMIE UNWIN | Commercial Insight Officer | Nanoform

Transfer targets

Tech transfer departments in Universities are inundated with potential translational science. How do they select the projects to back?


KEVIN COX | Chair | Biorelate


TOBY REID | Executive Director | We are Pioneer Group
RICH FERRIE | Chief Executive Officer | London BioInnovation Centre Ltd
SOHAIB MIR | Senior Investment Principal | LifeArc
RICHARD FAGAN | Director BioPharm | UCL Business

Preparing for the Next Pandemic

COVID-19 taught the life science industry a great deal. Now it’s time to capitalise on that knowledge. How can academia, SMEs and the government accelerate new solutions, overcome clinical, manufacturing, regulatory and commercialisation hurdles, and make sure we’re fully armed to tackle the next potential threat?


PHIL PACKER | Innovation Lead AMR and Vaccines | Innovate UK


ROBIN COHEN | Chief Commercial Officer | Emergex Vaccines
DORIS-ANN WILLIAMS MBE | Chief Executive | British In Vitro Diagnostics Association (BIVDA)
SHEULI PORKESS | Vice-President & Founder and Chief Medical Officer | Faculty of Pharmaceutical Medicine & Actaros Consultancy
JANET HEMINGWAY CBE | Professor of Tropical Medicine | Liverpool School of Tropical Medicine
DAME SARAH GILBERT | Saïd Professorship of Vaccinology | Nuffield Department of Medicine, University of Oxford

Where you lead

Selecting your lead investors and assembling your syndicate is pivotal to the success of a biotech. Do you pick your investors, or do they pick you?


NATHAN SIGWORTH | Co-founder and Chief Executive Officer |  PharmaCCX


JENNY LAIRD | Vice President, Search & Evaluation Pain & Neurodegeneration | Eli Lilly and Company
JOLYON MARTIN | Co-Founder and Head of Business Development | PetMedix
SONIA HOUGHTON| Chief Executive Officer & Co-Founder | Cryoniss
BRADLEY HARDIMAN | Head of UK/EU Search & Evaluation | Astellas Pharmaceuticals
HAKIM YADI OBE | Co-Founder and Chief Executive | Closed Loop Medicine

Closing Remarks

MARTINO PICARDO | Chairman | Discovery Park